Biopolymer-Based Therapeutics for Inflammation Modulation in Wound Care presents a comprehensive, biomarker-driven exploration of how natural and engineered biopolymers are transforming the management of acute, chronic, and non-healing wounds. Positioned at the intersection of biomaterials science, pharmaceutical innovation, and clinical practice, the book addresses one of the central challenges in wound care: persistent inflammation that delays tissue repair and regeneration. Beginning with the biological and clinical foundations of wound healing, the book systematically examines inflammatory pathways and key biomarkers such as TNF-?, IL-6, ROS, and VEGF.
It then advances into in-depth coverage of natural biopolymers-including collagen, chitosan, hyaluronic acid, silk-derived polymers, and marine polysaccharides-and their roles in immune modulation, macrophage polarization, and redox balance. Dedicated sections explore advanced delivery platforms such as nanofibers, smart hydrogels, nanozymes, and stimuli-responsive dressings, alongside emerging precision technologies including 3D printing and AI-guided material design. With a strong translational focus, the book bridges laboratory research and real-world application, addressing regulatory pathways, manufacturing scalability, and commercialization challenges.
- Provides comprehensive coverage of natural and advanced biopolymers for inflammation-modulated wound healing
- Presents strong translational perspectives that link biomarkers, material design, and clinical application
- Includes insights into emerging technologies, regulatory pathways, and commercialization strategies
